Included In This Lesson
Outline
What is the Generic Name
BROLUCIZUMAB
What is the Trade Name for BROLUCIZUMAB
BEOVU
What is the Indication for BROLUCIZUMAB
- 1 INDICATIONS AND USAGE BEOVU ® is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1 ).
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources